-
digital.ahrq.gov/sites/default/files/docs/medication-without-harm-slides-07242024.pdf
January 12, 2025 - She was subsequently confirmed to have phenytoin toxicity as a cause for her symptoms.
-
hcup-us.ahrq.gov/reports/statbriefs/sb254-Delivery-Hospitalizations-Substance-Use-Clinical-Outcomes-2016.pdf
January 01, 2016 - during pregnancy may lead to neonatal
abstinence syndrome (NAS), which is a constellation of signs and
symptoms
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa-2/004-ss-antimicrobial-prophylaxis-part-2.pptx
April 01, 2025 - Prophylaxis Part 2
| 27
Drug
Document the drug and allergy history accurately in the EHR
Reaction
Document symptoms
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2006_MaskedStats_Core_Weighted.PDF
January 01, 2006 - kidney and ureters 53179 0.04
162: Other diseases of bladder and urethra 29923 0.02
163: Genitourinary symptoms
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2006v2_MaskedStats_Core_Weighted.PDF
January 01, 2019 - kidney and ureters 53096 0.04
162: Other diseases of bladder and urethra 29310 0.02
163: Genitourinary symptoms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-decision-models_methods.pdf
July 01, 2012 - report focuses on the diagnosis of the
disease (AD) in the three scenarios of patients with suggestive symptoms
-
www.ahrq.gov/sites/default/files/wysiwyg/sdoh/sdoh-environmental-scan.xlsx
April 29, 2021 - 2017 N N N Y N Y Y Behavioral Risk Factor Surveillance System survey respondents who report asthma symptoms
-
psnet.ahrq.gov/web-mm/risks-malpositioned-gastrostomy-tube-and-poor-communication
August 01, 2012 - reported in the literature, although these complications may be underreported due to the lack of specific symptoms
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Rojas.pdf
March 15, 2004 - The Modified Rankin Scale is no symptoms at all (0); no significant
disability, able to carry out all
-
hcup-us.ahrq.gov/reports/statbriefs/sb248-Hospital-Readmissions-2010-2016.pdf
January 01, 2016 - malformations, deformations and
chromosomal abnormalities Q00–Q99
Conditions not elsewhere
classified
Symptoms
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Gallagher2.pdf
January 01, 2016 - This argues for closer monitoring of
patients postdischarge and making patients aware of the symptoms
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/hypertension-in-adults-screening
April 27, 2021 - the effectiveness of specific preventive care services for patients without obvious related signs or symptoms
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-weight-and-weight-gain-during-pregnancy-behavioral-counseling-interventions
May 25, 2021 - the effectiveness of specific preventive care services for patients without obvious related signs or symptoms
-
www.ahrq.gov/patient-safety/settings/hospital/vtguide/appa.html
July 01, 2018 - Many patients who develop a screening-detected DVT will resolve the DVT spontaneously and never have symptoms
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-dyslipidemia/statin-use-in-adults-preventive-medication-november-2016
November 13, 2016 - persons aged 25 to 44 years. 5
Because of the asymptomatic nature of dyslipidemia before signs or symptoms
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-diet-and-physical-activity-counseling-adults-with-high-risk-of-cvd
November 24, 2020 - the effectiveness of specific preventive care services for patients without obvious related signs or symptoms
-
digital.ahrq.gov/sites/default/files/docs/citation/developmentmethodsguide.pdf
September 01, 2012 - share quantitative information
on over 500 medical conditions, share information about sensitive
symptoms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol.pdf
November 03, 2014 - criteria, study design, comorbidities, other potential effect
modifiers (such as prior history of similar symptoms
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol3/Quinn.pdf
January 01, 2004 - beta-adrenergic blockade
among patients with insulin-dependent diabetes may be the concern that warning
symptoms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-depression-research-protocol.pdf
February 07, 2018 - the HAM-
D or MADRS scales
• Remission: commonly defined as absence or near absence of depressive
symptoms